Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea · Delayed Price · Currency is KRW 9,480.00
0.00 (0.00%)
At close: Feb 6, 2026
Hyundai Bioscience Market Cap
Hyundai Bioscience has a market cap or net worth of 910.43 billion as of February 6, 2026. Its market cap has increased by 51.42% in one year.
Market Cap
910.43B
Enterprise Value
881.07B
Revenue
1.96B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,480.00
Market Cap Chart
Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 910.43B, an increase of 1,816.92%. That is a compound annual growth rate of 13.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 910.43B | 90.94% |
| Dec 30, 2025 | 476.82B | -15.13% |
| Dec 30, 2024 | 561.85B | -45.92% |
| Dec 28, 2023 | 1.04T | -4.44% |
| Dec 29, 2022 | 1.09T | 11.39% |
| Dec 30, 2021 | 976.10B | -6.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.21T |
| Celltrion | 48.14T |
| ALTEOGEN | 19.31T |
| Sam Chun Dang Pharm. | 11.63T |
| SD Biosensor | 1.04T |
| Daewoong | 969.11B |
| MEDIPOST | 957.60B |
| Medy-Tox | 887.30B |